Neuro Advance
Date: Location: Cost:
October 10, 2018 Harvard Medical School - Joseph B. Martin Conference Center
77 Avenue Louis Pasteur
Boston, MA 02115

Starting at $1950

 

Dress Code:
Business Attire

Register

NEURO ADVANCE - OCTOBER 11, 2017

2018 AGENDA COMING SOON!

Time Agenda
7:30-8:30 am

Registration and Networking Breakfast

8:30-9:00 am

Welcome & Opening Remarks
Adam BruceCEO & Founder, TikoMed; Elliot EhrichEVP, R&D, AlkermesJonathan LewisCEO, Samus Therapeutics

9:00-9:30 am

Challenges of CNS Translational Research
Maria MaccecchiniPresident & CEO, QR Pharma; Anthony McKinneyFormer, Founder & CEO, NeurovanceDeborah RathjenCEO & Managing Director, Bionomics; Darryle SchoeppSVP & Head, Neuroscience, Merck
Moderator: Samantha Budd HaeberleinVP, Alzheimer's Disease Clinical Development, Biogen 

9:30-10:00 am

Financing Innovation in Neuroscience
Adam BruceCEO & Founder, TikoMed; John DelyaniExecutive Director, BD&L, Merck Research Laboratories; Erika Smith, CEOReNetX Bio; Amir TamizDirector, Division of Translational Research, NIH
Moderator: Bob SilvermanHead, Externalized Drug Discovery Partnering, Roche

10:00-10:30 am

Novel Approaches to Alzheimer’s Disease
Roger BullockCMO, Oryzon; John HoekmanCo-Founder & CEO, Impel Neuropharma; Leen KawasPresident & CEO, M3 Biotechnology; Kenneth MochPresident & CEO, Cognition Therapeutics
Moderator: Jonathan LewisCEO, Samus Therapeutics

10:30-11:00 am

Networking Break

11:00-11:30 am

Partnering in Neuroscience
Konrad Glund, 
CEO, Probiodrug AG; Klaus MendlaGlobal Head, CNS BD&L, Boehringer Ingelheim; Mark NuttallHead Immunology & MS Licensing & BD, Sanofi Genzyme; Christian SchubertStrategic Advisor, Biogen
Moderator: Rich DalyPresident & CEO, Neuralstem

11:30-12:00 pm

Digital Advances & Disruptive Innovation in Neuroscience
Eric GordonFounder, CEO & Chairman, Atentiv; Jonathan LewisCEO, Samus Therapeutics; Ana MaiquesCEO, Neuroelectrics
Moderator: Dan SmithSenior Director, Head of Translational Sciences, BlackThorn Therapeutics

12:00-1:15 pm

Networking Lunch

1:15-1:45 pm

Advances in Neurodegenerative, Neuromodulation, Neurostimulation, & Neurotrauma
Jesús Martin-Garcia, Chairman & CEO, GeNeuro SA; Lisa McKerracherCEO, BioAxone BioSciences; Alex WaldronCCO, Pear Therapeutics
Moderator: Ana MaiquesCEO, Neuroelectrics

1:45-2:30 pm

Advances in Genetics of Neurology & Psychiatry
Michael DavidsonCMO, Minerva Neurosciences; Robert LinkePresident & CEO, Embera NeuroTherapeutics; Jason UslanerExecutive DirectorNeuroscience, Pain & Symptomatics, Merck
Moderator: Robert GouldPresident & CEO, Fulcrum Therapeutics

2:30-3:00 pm

Networking Break

3:00-3:30 pm

Addressing Pain & Addiction
Danguole Altman
Founder, Vapogenix; Michael DetkeCMO, Embera NeuroTherapeutics; Randall StevensCMO, Centrexion; Alex TkachenkoCEO, Epiodyne
Moderator: Elliot EhrichEVP, R&D, Alkermes

3:30-4:15 pm

Advances: Neuroinflammation in Parkinson's Disease
Ole IsacsonProfessor, HMS & NyaCell Therapeutics; Spyros PapapetropoulosEVP, Head of R&D, CMO, Cavion; Kenneth RhodesCSO, Yumanity Therapeutics; Maurice ZaudererCEO, Vaccinex
Moderator: Jesse CedarbaumVP, Neurology Discovery & Development, Biogen

4:15-5:30 pm

Cocktails and Hors d'oeuvres

Supporting Sponsors: (see all sponsors)

<